Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Monolithic Power Systems Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Monolithic Power Systems Inc trades at $1,316.5 (market cap $66.46B). The key difference: Monolithic Power Systems Inc pays a 0.59% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | MPWR | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $1.69K |
52-Week Low | $23.09 | $711.24 |
Market Cap | — | $66.46B |
Enterprise Value | — | $65.11B |
Dividend Yield | — | 0.59% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MPWR trades at $1,352.74, down 1.56% over 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The company demonstrates strong profitability with a 22.98% net income margin and consistent earnings beats in recent quarters. Analyst sentiment is overwhelmingly positive with 88% buy ratings and a consensus price target of $1,760. Recent news highlights ongoing investigations into corporate governance alongside positive coverage of AI infrastructure growth opportunities.
The outlook for MPWR remains favorable given its earnings momentum and positioning in AI and power management semiconductors. Key opportunities include expanding demand in data centers and telecom, while risks involve high valuation multiples and corporate governance scrutiny. The stock offers growth potential but requires monitoring of execution against elevated expectations.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →